CS logo
small CS logo
S.C. Ematologia - Fondazione IRCCS Policlinico S. Matteo

Pavia, Italy
Hospital department in Pavia
Piazzale Camillo Golgi, 17, 27100 Pavia PV

About S.C. Ematologia - Fondazione IRCCS Policlinico S. Matteo


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at S.C. Ematologia - Fondazione IRCCS Policlinico S. Matteo


During the past decade, S.C. Ematologia - Fondazione IRCCS Policlinico S. Matteo conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 6 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment

Rows per page:

0–0 of 0

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "S.C. Ematologia - Fondazione IRCCS Policlinico S. Matteo" #1 sponsor was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 17 trials, followed by "Fondazione Italiana Linfomi ONLUS" with 15 trials sponsored, "Hoffmann-La Roche" with 6 trials sponsored, "Fondazione per la Ricerca Ospedale Maggiore" with 4 trials sponsored and "Gruppo Italiano Trapianto di Midollo Osseo" with 4 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "S.C. Ematologia - Fondazione IRCCS Policlinico S. Matteo" #1 collaborator was "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 3 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "AOP Orphan Pharmaceuticals AG" with 1 trials as a collaborator, "AbbVie" with 1 trials as a collaborator and "Biogen" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNational CancerInstitute (NCI): 106National CancerInstitute (NCI): 106SWOG Cancer ResearchNetwork: 45SWOG Cancer ResearchNetwork: 45Alliance for ClinicalTrials in Oncology: 37Alliance for ClinicalTrials in Oncology: 37ECOG-ACRIN CancerResearch Group: 19ECOG-ACRIN CancerResearch Group: 19NRG Oncology: 8NRG Oncology: 8Wake Forest UniversityHealth Sciences: 5Wake Forest UniversityHealth Sciences: 5Gynecologic Oncology Group: 3Gynecologic Oncology Group: 3Children's Oncology Group: 2Children's Oncology Group: 2GOG Foundation: 2GOG Foundation: 2University of RochesterNCORP Research Base:2University of RochesterNCORP Research Base:2

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 122National CancerInstitute (NCI): 122NRG Oncology: 20NRG Oncology: 20Canadian Cancer Trials Group: 9Canadian Cancer Trials Group: 9MillenniumPharmaceuticals, Inc.: 2MillenniumPharmaceuticals, Inc.: 2Agenus Inc.: 1Agenus Inc.: 1Astellas Pharma US, Inc.: 1Astellas Pharma US, Inc.: 1Bayer: 1Bayer: 1Biologics, Inc.: 1Biologics, Inc.: 1Brain Science Foundation: 1Brain Science Foundation: 1Cancer PreventionPharmaceuticals, Inc.: 1Cancer PreventionPharmaceuticals, Inc.: 1

Clinical Trials Conditions at S.C. Ematologia - Fondazione IRCCS Policlinico S. Matteo


According to Clinical.Site data, the most researched conditions in "S.C. Ematologia - Fondazione IRCCS Policlinico S. Matteo" are "Chronic Myeloid Leukemia" (5 trials), "Acute Promyelocytic Leukemia" (3 trials), "Chronic Lymphocytic Leukemia" (3 trials), "Follicular Lymphoma" (3 trials) and "Myelofibrosis" (3 trials). Many other conditions were trialed in "S.C. Ematologia - Fondazione IRCCS Policlinico S. Matteo" in a lesser frequency.

Clinical Trials Intervention Types at S.C. Ematologia - Fondazione IRCCS Policlinico S. Matteo


Most popular intervention types in "S.C. Ematologia - Fondazione IRCCS Policlinico S. Matteo" are "Drug" (35 trials), "Other" (8 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Rituximab" (6 trials), "Bendamustine" (4 trials), "Cyclophosphamide" (3 trials), "Doxorubicin" (2 trials) and "Ibrutinib" (2 trials). Other intervention names were less common.

Clinical Trials Genders at S.C. Ematologia - Fondazione IRCCS Policlinico S. Matteo


The vast majority of trials in "S.C. Ematologia - Fondazione IRCCS Policlinico S. Matteo" are 46 trials for "All" genders.

Clinical Trials Status at S.C. Ematologia - Fondazione IRCCS Policlinico S. Matteo


Currently, there are NaN active trials in "S.C. Ematologia - Fondazione IRCCS Policlinico S. Matteo". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in S.C. Ematologia - Fondazione IRCCS Policlinico S. Matteo, undefined suspended trials, and 5 terminated clinical trials to date.
Out of the total trials that were conducted in S.C. Ematologia - Fondazione IRCCS Policlinico S. Matteo, 0 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 118Phase 2: 118Phase 3: 113Phase 3: 113Phase 1: 9Phase 1: 9Not Applicable: 4Not Applicable: 4Early Phase 1: 1Early Phase 1: 1

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 100Active, not recruiting: 100Recruiting: 86Recruiting: 86Completed: 29Completed: 29Suspended: 7Suspended: 7Terminated: 7Terminated: 7Unknown status: 1Unknown status: 1